A Study of LY3437943 in Participants With Impaired and Normal Liver Function

NCT05916560 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Hepatic Insufficiency

Interventions

DRUG: LY3437943

Sponsor

Eli Lilly and Company